FACS-Assisted CRISPR-Cas9 Genome Editing Facilitates Parkinson's Disease Modeling

Genome editing and human induced pluripotent stem cells hold great promise for the development of isogenic disease models and the correction of disease-associated mutations for isogenic tissue therapy. CRISPR-Cas9 has emerged as a versatile and simple tool for engineering human cells for such purpos...

Descripción completa

Detalles Bibliográficos
Autores principales: Arias-Fuenzalida, Jonathan, Jarazo, Javier, Qing, Xiaobing, Walter, Jonas, Gomez-Giro, Gemma, Nickels, Sarah Louise, Zaehres, Holm, Schöler, Hans Robert, Schwamborn, Jens Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830965/
https://www.ncbi.nlm.nih.gov/pubmed/28988985
http://dx.doi.org/10.1016/j.stemcr.2017.08.026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830965/
https://www.ncbi.nlm.nih.gov/pubmed/28988985
http://dx.doi.org/10.1016/j.stemcr.2017.08.026

Ejemplares similares